CNMD · NYSE
CNMD · NYSE
43.90 USD
-1.82 (-3.99%)
CONMED fell 2.9% as the S&P 500 and Nasdaq sold off sharply and volatility jumped. The decline followed CONMED's October 28 third-quarter results and updated full-year guidance source, while JPMorgan kept a Neutral rating and raised its price target. Stryker's lowered outlook added pressure across surgical-device sentiment.
CONMED fell 2.9% as the S&P 500 and Nasdaq sold off sharply and volatility jumped. The decline followed CONMED's October 28 third-quarter results and updated full-year guidance source, while JPMorgan kept a Neutral rating and raised its price target. Stryker's lowered outlook added pressure across surgical-device sentiment.